loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday
.
.
.
.
.